Experimental Drug for HPV-Linked Recurrent Respiratory Papillomatosis Shows Early Promise
According to a press release from Inovio Pharmaceuticals, the American biotech company's experimental recurrent respiratory papillomatosis (RRP) drug INO-3106 showed promising results at the end of a pilot clinical study…